|

Liver Ischemia-reperfusion Injury and Clinical Data Analysis

RECRUITINGSponsored by Qin Zhang
Actively Recruiting
SponsorQin Zhang
Started2023-10-10
Est. completion2023-12-20
Eligibility
Age18 Years – 70 Years
View on ClinicalTrials.gov →

NCT06080308

Summary

Searching for new targets for the diagnosis and treatment of liver ischemia-reperfusion injury.

Eligibility

Age: 18 Years – 70 Years
Inclusion Criteria:

1. Willingness to participate in the study and has signed an informed consent form. 2) Age ≥ 18 years and ≤ 70 years. 3) ASA classification ≤ III. 4) Criteria for liver ischemia-reperfusion injury patients: patients undergoing elective liver resection surgery with hepatic pedicle occlusion and reperfusion during the procedure.

Exclusion Criteria:

1\) Patients with adverse events during surgery. 2) Patients in the end stage of disease with liver failure. 3) Liver tumor metastasis with concomitant severe heart failure or chronic renal insufficiency, etc. 4) Deemed unsuitable for participation in the study based on the judgment of the researchers.

\-

Conditions2

Liver DiseaseLiver Injury

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.